dichlororibofuranosylbenzimidazole has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, S; Frame, S; Gianella-Borradori, A; Green, SR; Lane, DP; MacCallum, DE; Melville, J; Watt, K | 1 |
| Klibanov, SA; Ljungman, M; O'Hagan, HM | 1 |
| Bertolotto, C; Bourcier, C; Grépin, R; Griseri, P; Mazure, N; Pagès, G | 1 |
3 other study(ies) available for dichlororibofuranosylbenzimidazole and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.
Topics: Apoptosis; Cell Line, Tumor; Dichlororibofuranosylbenzimidazole; Down-Regulation; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Multiple Myeloma; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Purines; RNA Polymerase II; RNA, Messenger; Roscovitine; Transcription, Genetic | 2005 |
Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress.
Topics: Blotting, Northern; Cell Nucleolus; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dichlororibofuranosylbenzimidazole; Diffusion; Fibroblasts; Gene Expression; Humans; Leupeptins; Multienzyme Complexes; Nuclear Proteins; Nucleolin; Phosphoproteins; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; RNA Polymerase II; RNA-Binding Proteins; RNA, Messenger; Solubility; Transcription, Genetic; Tumor Suppressor Protein p53; Ultraviolet Rays | 2001 |
Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.
Topics: Animals; Antibodies; Antineoplastic Agents; Apoptosis; Autophagy; Benzamides; Benzenesulfonates; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL1; Chemokine CXCL5; Dichlororibofuranosylbenzimidazole; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Genes, Reporter; Half-Life; Humans; Immunotherapy, Active; Interleukin-8; Leupeptins; MAP Kinase Kinase Kinases; Melanoma; Membrane Proteins; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Niacinamide; Phenylurea Compounds; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins; Pyridines; Receptors, Interleukin-8B; RNA Stability; RNA, Messenger; RNA, Small Interfering; Sorafenib; Transfection; Tristetraprolin; Tumor Cells, Cultured; Vaccination | 2011 |